Tofacitinib 11mg, 22mg; ext-rel tabs. Swallow whole. 11mg once daily. Switching from immediate-rel to XR tabs: start XR tab the day following the last immediate-rel 5mg dose. Moderate to severe ...
The FDA has concluded its safety review of Pfizer's JAK inhibitor Xeljanz and Xeljanz XR, requiring revised warnings for the drugs as well as others in the class after finding evidence of elevated ...
JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. Now, a study designed to prove its safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback